Literature DB >> 3177546

Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

G M Rodgers1, R N Taylor, J M Roberts.   

Abstract

Preeclampsia occurs in 7% to 10% of pregnancies and is a leading cause of morbidity for mothers and their infants. Intensive investigation has failed to reveal the cause of the multiple organ dysfunction characteristic of this disorder, which abates completely with delivery. However, several observations suggest that endothelial cell dysfunction is a central pathophysiologic event. We report that serum from preeclamptic women is cytotoxic to endothelial cells in vitro. Consistent with the reversal of the clinical condition after delivery, cytotoxic activity in serum of preeclamptic women is reduced after 24 to 48 hours post partum. In contrast, cytotoxic activity of serum from normal pregnant women increases after delivery.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177546     DOI: 10.1016/s0002-9378(88)80169-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  29 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

3.  Lipoprotein levels in patients with pregnancy induced hypertension.

Authors:  A Uslu; T Uslu; F Bingöl; S Aydin
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

4.  Plasma antioxidant vitamins and lipid peroxidation products in pregnancy induced hypertension.

Authors:  G M Rao; P Sumita; M Roshni; M N Ashtagimatt
Journal:  Indian J Clin Biochem       Date:  2005-01

5.  A role for sleep disorders in pregnancy complications: challenges and opportunities.

Authors:  Roberto Romero; M Safwan Badr
Journal:  Am J Obstet Gynecol       Date:  2014-01       Impact factor: 8.661

Review 6.  Vascular Dysfunction in Mother and Offspring During Preeclampsia: Contributions from Latin-American Countries.

Authors:  Fernanda Regina Giachini; Carlos Galaviz-Hernandez; Alicia E Damiano; Marta Viana; Angela Cadavid; Patricia Asturizaga; Enrique Teran; Sonia Clapes; Martin Alcala; Julio Bueno; María Calderón-Domínguez; María P Ramos; Victor Vitorino Lima; Martha Sosa-Macias; Nora Martinez; James M Roberts; Carlos Escudero
Journal:  Curr Hypertens Rep       Date:  2017-10-06       Impact factor: 5.369

Review 7.  Why is placentation abnormal in preeclampsia?

Authors:  Susan J Fisher
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

8.  Study of Nitrosative Stress in 'Pregnancy Induced Hypertension'.

Authors:  Kapila B Gaikwad; Nitin G Joshi; Sohan P Selkar
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

10.  Alpha-hemoglobin-stabilizing protein (AHSP) in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome, intrauterine growth restriction (IUGR) and fetal death.

Authors:  Monica Emanuelli; Davide Sartini; Valentina Rossi; Alessandra Corradetti; Beatrice Landi; Claudia Regina Vianna; Stefano Giannubilo; Andrea Luigi Tranquilli
Journal:  Cell Stress Chaperones       Date:  2008-02-06       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.